CYTX Insider Trading Activity and SEC Form 4 Filings
CYTX insider trading summary
No open-market insider purchases or sales of Cytori Therapeutics, Inc. (CYTX) have been reported on SEC Form 4 in the past 12 months.
Latest CYTX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Feb 14, 2018 | AG PostFinance | 10% Owner | Sell | $161K (473,831 @ $0.34) |
| Feb 13, 2018 | AG PostFinance | 10% Owner | Sell | $32K (101,710 @ $0.31) |
| Feb 12, 2018 | AG PostFinance | 10% Owner | Sell | $58K (185,272 @ $0.31) |
| Feb 9, 2018 | AG PostFinance | 10% Owner | Sell | $3K (7,552 @ $0.34) |
| Feb 8, 2018 | AG PostFinance | 10% Owner | Sell | $78K (228,603 @ $0.34) |
| Jan 11, 2018 | Swissquote Bank SA | Insider | Sell | $4K (12,630 @ $0.34) |
| Jan 11, 2018 | Swissquote Bank SA | Insider | Sell | $7K (20,000 @ $0.34) |
| Jan 11, 2018 | Swissquote Bank SA | Insider | Sell | $7K (20,000 @ $0.34) |
| Jan 11, 2018 | Swissquote Bank SA | Insider | Sell | $7K (20,000 @ $0.34) |
| Jan 10, 2018 | Swissquote Bank SA | Insider | Sell | $6K (15,796 @ $0.38) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.